Use access key #2 to skip to page content.
$16.41 1.44 (9.62%)
10/13/2008 4:00 PM

GTx, Inc. (GTXI)

CAPS Rating:
**

A biopharmaceutical company dedicated to the discovery, development & commercialization of small molecules that selectively target hormone pathways to treat cancer, osteoporosis & bone loss, muscle wasting & other serious medical conditions.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating GTXI

Add Stock to Watchlist

What the Community Thinks

Total Members

70 Outperforms
20 Underperforms
 

All-Stars

12 Outperforms
11 Underperforms
 

Wall Street

8 Outperforms
1 Underperforms
 

Members bullish on GTXI are also bullish on:

Members bearish on GTXI are also bearish on:

Ticker Tags

Biotechnology (295), Small Cap (1922), Micro Cap (4824)
Suggest a tag

GTx, Inc. At A Glance

Current Price: $16.41
Last Trade Time: 10/13/2008 4:00 PM
Open: $16.76
Previous Close: $14.97
Daily Range: $15.36 - $17.14
52-Week Range: $10.75 - $20.20
Volume: 442,610
Market Cap: $543.93M
P/E Ratio: 0.00
Compare Our Special Broker Offers!

Stock Trends

GTXI VS S&P 500 (SPY)

GTXI 12 month chart vs. S&P

News & Discussion Boards

Other News Headlines for GTXI

More Headlines...

Top Bull Pitch

Recs

1

GTx, Inc. (GTXI)

Avatar DANSEVILLE (< 20) Submitted: 4/10/08 9:33 PM

THERE ARE SEVERAL OPTIONS ON THE TABLE NOW. THERE WILL BE AN ANNOUCEMENT APRIL 12-15 CONCERNING THE FINAL TRAILS OF THEIR DRUGS

Replies: 0 | Reply | Permalink

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 15 :   1 2 3 Next »

Recs

0

 (GTXI)

Avatar EclecticRecluse (75.10) Submitted: 10/13/08 7:12 AM : Underperform Start Price: $16.76 GTXI Score: 9.22

Extremely High Price for Sales

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (GTXI)

Avatar biovestor (< 20) Submitted: 6/28/08 6:29 AM : Outperform Start Price: $14.63 GTXI Score: 32.06

Promisng treatment for prostate cancer in late-stage development likely to fuel gains for GTXI over the next year or so.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (GTXI)

Avatar crl2007 (57.37) Submitted: 5/29/08 10:29 AM : Outperform Start Price: $15.40 GTXI Score: 33.11

s+p strong buy, reuters rated out-perform, target price $27

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (GTXI)

Avatar Tankota (99.81) Submitted: 5/15/08 1:03 PM : Underperform Start Price: $16.19 GTXI Score: -29.11

off target.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (GTXI)

Avatar johnearl12 (< 20) Submitted: 5/04/08 9:09 PM : Outperform Start Price: $18.21 GTXI Score: 17.75

It has a couple of Phase lll trials going on. It is about ready to pop. Great short term possibilities and great long term too. It has good buzz in the market place. Several reports state it will have unbelievable growth when the products hit the market soon.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 15 :   1 2 3 Next »

Wall Street

Results 1 - 9 of 9  

picks per page. CHANGE

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackJimCramer 82.41 05/14/08 Underperform 3W $15.85+0.95%-29.74%-30.69
TrackRodmanRen 23.71 03/25/08 Outperform NS $14.92+7.24%-26.66%+33.90
TrackScottBleier 58.14 12/21/07 Outperform 3M $15.46+3.49%-33.23%+36.73
TrackBroadpointC 33.33 11/06/07 Outperform NS $15.88+0.76%-34.54%+35.29
TrackWachovia < 20 10/11/07 Outperform NS $17.81-10.16%-36.98%+26.82
TrackLazardCapit < 20 02/26/07 Outperform NS $21.33-24.99%-32.00%+7.01
TrackAGEdwards 84.99 12/06/06 Outperform NS $16.60-3.61%-30.03%+26.42
TrackHSBC 88.02 09/08/06 Outperform NS $9.00+77.78%-23.97%+101.75
TrackFirstAlbany 78.86 08/30/06 Outperform NS $8.94+78.97%-24.43%+103.40

Results 1 - 9 of 9  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners